Metal-on-Metal Hip Replacement Devices Implanted After 2006 Have a High Revision Rate

Certain metal-on-metal (MoM) hip replacement devices implanted after 2006 have an “unacceptably high” revision rate, due mainly to manufacturing problems, according to a new study.

“Although the use of MoM hip devices has declined dramatically in the past five years, hundreds of thousands remain in situ, with the long-term future uncertain,” Dr. David Langton, of University Hospital of North Tees in Stockton, UK, and colleagues wrote in an article online April 29 in BMJ Open.

To determine risk factors for revision in patients implanted with the commonly used DePuy Pinnacle MoM hip prostheses, the researchers identified all patients at the Stockton-based hospital who were implanted with a 36 mm MoM Pinnacle hip in conjunction with an S-ROM or Corail uncemented stem. They then identified only patients with components that had been implanted by either of the two senior authors of the study, Dr. Raj Logishetty or Dr. Antoni Viral Francis Nargol.

Implantations were performed from 2003-2009 and patients were monitored yearly. From 2007-2011, as awareness of the risk of adverse reactions to metal debris (ARMD) from MoMs increased, the hospital offered patients who developed symptoms blood metal ion testing and as-needed ultrasound scanning. From 2011 onward, given the widespread problems reported with MoMs, the hospital recalled all Pinnacle MoM patients for examination.
A total of 489 MoM Pinnacle hips had been implanted into 243 women and 191 men. Of these, 352 patients attended the MoM recall clinics and 64 died during the study period (mean follow-up, about 7.5 years). For the purposes of survival analyses, those who did not attend the recall clinics were assumed to have well-functioning prostheses.

A total of 71 hips were revised — an “unacceptably high” rate, according to the authors. All but one were carried out for ARMD, with one revision for a loose cup. Prosthetic survival rate for the cohort as a whole was 83.6% at nine years.

In 53 revisions (75%), “copious amounts” of fluid were found, and in 32 (45%), it was noted to be under pressure or had fistulated through the capsule. No abnormal fluid was identified at revision in only one case.

The researchers noted obvious damage to the abductor musculature in 38 cases. They documented a moderate-to-severe aseptic lymphocyte-dominated vasculitis-associated lesion on examination of retrieved tissues in 36 cases (51%). In 13 cases (19%), they found metallosis with no identified lymphocytic infiltration.

The majority of explanted devices showed signs of taper junction failure. A significant number of devices were found to be manufactured out of their specifications — a finding that was confirmed by an analysis of a wider data set from the Northern Retrieval Registry.

Risk factors for revision were bilateral MoM prostheses, smaller Pinnacle liners, and implantation in 2006 or later. Women were found to be at greater risk of early device failure. However, shell sizes and bearing diameters confounded the analyses, and liner size and/or earlier year of liner manufacture were determined to be greater threats to prosthetic survival than gender. The authors suggest that this analysis be repeated with input from an additional registry.

Dr. Langton, who is involved in litigation related to the Pinnacle device, told Reuters Health by email, “We have essentially shown that one of the major health care/orthopedic product manufacturers sold a product to surgeons and health care systems on the basis (that it was a) technologically advanced precision-engineered device, and it wasn’t precision-engineered.”

He added, “the product was produced in the same factories as (DePuy’s) other failed product, the ASR, which was . . . marketed on the same premise.” Mindy Tinsley, senior director, Communications and Public Affairs at DePuy Synthes Franchise, refuted the study findings. “We stand behind the strong record of safety and effectiveness of the (Pinnacle) ULTAMET Metal-on-Metal,” she told Reuters Health by email.

She added that “there are no manufacturing problems” with the device and noted that DePuy “questions the validity of the . . . paper given significant flaws in how it was conducted.” According to Tinsley, “measurements taken following an accepted international standard at the DePuy UK manufacturing facility” showed the device liners “were manufactured within specification.”

Dr. Mark W. Hungerford, director of Joint Replacement and Reconstruction at Mercy Medical Center in Baltimore, told Reuters Health by phone, “One study does not make or break anything in science. There have been issues in the field about MoM and early failure rates or not. That’s a serious issue being looked at by a lot of people. This is one more study showing a problem, but it’s not a definitive one.”

With respect to patients, “the obligation is no different than for any orthopedic device,” said Dr. Hungerford, who has not used the Pinnacle device. “All can fail, all need to be monitored for failure on a regular basis, and if problems arise, they need to be dealt with.”

The authors reported no funding. Dr. Langton, Dr. Nargol, and coauthors Dr. Thomas Joyce and Dr. Nick Cooke are retained experts for plaintiffs in ongoing MoM litigation. Dr. Langton and Dr. Nargol have worked with the U.S. Department of Justice in litigation involving DePuy.

For Further Information
More on the hip replacement device market in the United States can be found in a report suite published by iData Research entitled US Market for Orthopedic Large Joint Replacement Devices. The suite covers reports on the following markets: Knee Replacement Device Market, Hip Replacement Device Market, and Bone Cement Market.

The iData report series on large joint replacement devices covers the United States, China, India, Japan, Australia, South Korea, Brazil, and 15 countries in Europe. Reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. To find out more about knee replacement market data or procedure data, register online or email us at [email protected] for a US Market for Orthopedic Large Joint Replacement Devices brochure and synopsis.

About Procedure Tracker
Procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by state, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.

Explore our careers page for our current available job opportunities. This is your chance to join a fun and dynamic team in the medical market research industry. Send your resume to [email protected] with the job title in the subject line, and feel free to tell us a little about yourself. We look forward to hearing from you.

Categories

Social Links

?Want more information about the market report mentioned in this article?

Subscribe to iData News

We publish medical, dental, and pharmaceutical news and market insights from our analysts every day. Sign up for your free subscription here:

Leave this field empty if you’re human:

What we do

iData Research is an international market research and consulting firm, dedicated to providing the best in business intelligence for the medical device industry. Our research empowers our clients by providing them with the necessary tools to achieve their goals and do it right the first time.

We have built a reputation and earned our clients’ trust based on consistent and uniquely intelligent research that allows our customers to make confident decisions and impact their businesses. A combination of market expertise and over a decade of experience has resulted in a deep understanding of the medical device industry that has inspired innovation and propelled our clients to success.

Social Links

FREE Report Download

Ulcerative Colitis Drugs Market in the United States 2018 - 2023

Special Limited Time Giveaway:
Register to download a full report on the United States market for Ulcerative Colitis drugs (Valued at over $3000 with market values, competitor shares, annual drug cost and much more). This is one full section from the global package which covers 12 countries and 5 immunology diseases.

The download link will be emailed to the address entered in this box. You may unsubscribe or manage your email subscription settings anytime after downloading.

FREE Report Download

Global Cardiology Survey Results

This 63-page report covers hundreds of survey responses from 59 different countries. Gain insight into these top cardiology product preferences and decision reasons to improve your marketing strategy.

The download link will be emailed to the address entered in this box. You may unsubscribe or manage your email subscription settings anytime after downloading.

FREE Report Download

Global Orthopedic Surgeon Survey

This 44-page report covers hundreds of survey responses from 37 different countries. Gain insight into these top orthopedic physician product preferences and decision reasons to improve your marketing strategy.

The download link will be emailed to the address entered in this box. You may unsubscribe or manage your email subscription settings anytime after downloading.

Login

FREE Whitepaper Download

The State of the US Dental Market

This free whitepaper is your entrance point to knowledge about the dental market in the United States. This analysis covers the major market values and growth trends for 9 different markets and provides the leading competitors in each.

The download link will be emailed to the address entered in this box. You may unsubscribe or manage your email subscription settings anytime after downloading.

Ultimate Guide to Buying

Medical Market Research [Free Download]

Discover the secrets to comparing medical market research firms and how to confidently choose one that fits your needs.
These 11 simple questions
to ask will help you investigate your potential research partners and ensure you make the right decision the first time.

The download link will be emailed to the address entered in this box. You may unsubscribe or manage your email subscription settings anytime after downloading.